Latest News

14 March 2019
Insights

The world-wide number of pre-clinical drugs under development over 2017-2018 increased from 7493 to 8040, a whopping 7.3% (1). The largest class of these drugs, synthetic chemicals, increased from 7855 to 7992 throughout the same period. The second largest, antibody drugs, similarly showed considerable growth from 1687 to 1809 (7.2%). Overall the largest therapeutic class, […]


Make an enquiry

Send us your details, and one of
our expert team will be in touch